Oreola Donini
8Patents
1h-index
6Co-inventors
40Inventor score
Filing activity: Oct 4, 2006 → Sep 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8124721B2 | Peptides for modulating innate immunity | Emerging Cross-Sectional Technologies | 2 | Active |
| US11433129B2 | Compositions and methods of manufacturing trivalent filovirus vaccines | Emerging Cross-Sectional Technologies | 1 | Active |
| US9416157B2 | Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity | Emerging Cross-Sectional Technologies | 0 | Active |
| US10253068B2 | Peptides and analogs for use in the treatment of oral mucositis | Chemistry; Metallurgy | 0 | Active |
| US11311598B2 | Peptides and analogs for use in the treatment of oral mucositis | Human Necessities | 0 | Active |
| US8791061B2 | Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity | Emerging Cross-Sectional Technologies | 0 | Active |
| US9850279B2 | Peptides and analogs for use in the treatment of oral mucositis | Chemistry; Metallurgy | 0 | Active |
| US11771757B2 | Compositions and methods of manufacturing trivalent filovirus vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.